tirzepatide 17/2 Flex-Dose 2 mL Injectable 10 mg/mL Tirzepatide / Niacinamide Injection |
Description
Eli Lilly has disclosed the structure of its next-generation small molecule GLP-1R agonist, naperiglipron (LY3549492), at a pivotal moment for the class
Available now for: Wholesale orders
very low-certainty evidence)
Vaxess Technologies rebrands as Terrestrial Bio, raises $50M to pivot from vaccines to GLP-1 patches for semaglutide delivery, after AstraZeneca partnership ends.
Psychiatrist Amit Anand, MD, explains the potential benefits and risks.
